Literature DB >> 18162176

The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.

Ignacio J Juncadella1, Renu Garg, Tonya C Bates, Elias R Olivera, Juan Anguita.   

Abstract

Ixodes scapularis salivary protein, Salp15, inhibits CD4(+) T cell activation by binding to the most-extracellular domains of the CD4 molecule, potentially overlapping with the gp120-binding region. We now show that Salp15 inhibits the interaction of gp120 and CD4. Furthermore, Salp15 prevents syncytia formation between HL2/3 (a stable HeLa cell line expressing the envelope protein) and CD4-expressing cells. Salp15 prevented gp120-CD4 interaction at least partially through its direct interaction with the envelope glycoprotein. A phage display library screen provided the interacting residues in the C1 domain of gp120. These results provide a potential basis to define exposed gp120 epitopes for the generation of neutralizing vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162176      PMCID: PMC2238774          DOI: 10.1016/j.bbrc.2007.12.104

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

Authors:  C Vita; E Drakopoulou; J Vizzavona; S Rochette; L Martin; A Ménez; C Roumestand; Y S Yang; L Ylisastigui; A Benjouad; J C Gluckman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 3.  Unwelcome guests with master keys: how HIV enters cells and how it can be stopped.

Authors:  Robert W Doms
Journal:  Top HIV Med       Date:  2004 Oct-Nov

4.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

5.  Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.

Authors:  Cynthia S Dowd; Stephanie Leavitt; Gregory Babcock; Alexis P Godillot; Don Van Ryk; Gabriela A Canziani; Joseph Sodroski; Ernesto Freire; Irwin M Chaiken
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

6.  Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4.

Authors:  L Briant; N Signoret; M Gaubin; V Robert-Hebmann; X Zhang; R Murali; M I Greene; D Piatier-Tonneau; C Devaux
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

Review 7.  Chemokine receptors as new molecular targets for antiviral therapy.

Authors:  F Santoro; L Vassena; P Lusso
Journal:  New Microbiol       Date:  2004-04       Impact factor: 2.479

8.  Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation.

Authors:  Juan Anguita; Nandhini Ramamoorthi; Joppe W R Hovius; Subrata Das; Venetta Thomas; Rafal Persinski; Dietrich Conze; Philip W Askenase; Mercedes Rincón; Fred S Kantor; Erol Fikrig
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 9.  The HIV Env-mediated fusion reaction.

Authors:  Stephen A Gallo; Catherine M Finnegan; Mathias Viard; Yossef Raviv; Antony Dimitrov; Satinder S Rawat; Anu Puri; Stewart Durell; Robert Blumenthal
Journal:  Biochim Biophys Acta       Date:  2003-07-11

10.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.

Authors:  P D Kwong; R Wyatt; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

View more
  5 in total

1.  Novel immunomodulators from hard ticks selectively reprogramme human dendritic cell responses.

Authors:  Stephen G Preston; Juraj Majtán; Chrisoula Kouremenou; Oliwia Rysnik; Lena F Burger; Alejandro Cabezas Cruz; Maylin Chiong Guzman; Miles A Nunn; Guido C Paesen; Patricia A Nuttall; Jonathan M Austyn
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

Review 2.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

3.  An Immunosuppressant Peptide from the Hard Tick Amblyomma variegatum.

Authors:  Yufeng Tian; Wenlin Chen; Guoxiang Mo; Ran Chen; Mingqian Fang; Gabriel Yedid; Xiuwen Yan
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

Review 4.  Tick Salivary Compounds for Targeted Immunomodulatory Therapy.

Authors:  Hajer Aounallah; Chaima Bensaoud; Youmna M'ghirbi; Fernanda Faria; Jindr Ich Chmelar; Michail Kotsyfakis
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

5.  Identification of Aedes aegypti salivary gland proteins interacting with human immune receptor proteins.

Authors:  Edem Gavor; Yeu Khai Choong; Yonghao Liu; Julien Pompon; Eng Eong Ooi; Yu Keung Mok; Haiyan Liu; R Manjunatha Kini; J Sivaraman
Journal:  PLoS Negl Trop Dis       Date:  2022-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.